Cells navigating in complex microenvironments frequently encounter narrow spaces that physically challenge migration.

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra (fo ...

As cognitive fatigue increased, subjects increased their response criterion. For ease of interpretation, the “raw,” un-transformed VAS-F scores are shown in the plot. VAS-F, visual analog scale of ...

John Warner argues for the fundamental irrelevance of LLMs to the parts of the heart and mind that we unlock through the ...